Drug Shortage Report for LIDOCAINE HYDROCHLORIDE INJECTION

Last updated on 2023-10-14 History
Report ID 205384
Drug Identification Number 02522268
Brand name LIDOCAINE HYDROCHLORIDE INJECTION
Common or Proper name LIDOCAINE HYDROCHLORIDE INJECTION
Company Name LABORATOIRE AGUETTANT
Market Status MARKETED
Active Ingredient(s) LIDOCAINE HYDROCHLORIDE
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 x 5 mL
ATC code C01BB
ATC description ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2023-09-28
Actual start date 2023-10-06
Estimated end date 2023-10-16
Actual end date 2023-10-13
Shortage status Resolved
Updated date 2023-10-14
Company comments Delay in receiving product
Health Canada comments
Tier 3 Status No
Contact Address 1, RUE ALEXANDER FLEMING
LYON, RHÔNE
FRANCE 69007
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-10-14 English Compare
v11 2023-10-13 French Compare
v10 2023-10-13 English Compare
v9 2023-10-13 English Compare
v8 2023-10-11 French Compare
v7 2023-10-11 English Compare
v6 2023-10-06 French Compare
v5 2023-10-06 English Compare
v4 2023-09-29 English Compare
v3 2023-09-28 French Compare
v2 2023-09-28 French Compare
v1 2023-09-28 English Compare

Showing 1 to 12 of 12